Advances in the Combination Therapy of Targeted Anti-Cancer Drugs
نویسندگان
چکیده
2016; 4(2): 94-98 http://www.sciencepublishinggroup.com/j/sd doi: 10.11648/j.sd.20160402.17 ISSN: 2331-0642 (Print); ISSN: 2331-0650 (Online) Advances in the Combination Therapy of Targeted Anti-Cancer Drugs Jie Yang * , Yan Wu, Zhen Wu, Yong-Tao Cui, Xiao-Qi Peng Patent Examination Cooperation Center of the Patent Office, SIPO, Beijing, China Email address: [email protected] (Jie Yang), [email protected] (Yan Wu), [email protected] (Zhen Wu), [email protected] (Yong-Tao Cui), [email protected] (Xiao-Qi Peng) Corresponding author To cite this article: Jie Yang, Yan Wu, Zheng Wu, Yong-Tao Cui, Xiao-Qi Peng. Advances in the Combination Therapy of Targeted Anti-Cancer Drugs. Science Discovery. Vol. 4, No. 2, 2016, pp. 94-98. doi: 10.11648/j.sd.20160402.17 Received: April 27, 2016; Accepted: May 16, 2016; Published: May 18, 2016 Abstract: The combination therapy of targeted anti-cancer drugs is important in the research of anti-cancer drugs. This articleintroduced the status of combination therapy of the same targeted and different targeted anti-cancer drugs, and analyzed the challenges and difficulties. In order to provide reference basis for development of combination therapy technique of targeted anti-cancer drugs in China.
منابع مشابه
In vitro combination therapy of pathologic angiogenesis using anti-vascular endothelial growth factor and anti-neuropilin-1 nanobodies
Objective(s): Emergence of resistant tumor cells to the current therapeutics is the main hindrance in cancer treatment. Combination therapy, which mixes two or more drugs, is a way to overcome resistant problems of cancer cells to current treatments. Nanobodies are promising tools in cancer therapy due to their high affinity as well as high penetration to tumor sites....
متن کاملInduction of Apoptosis and Non-Apoptosis in Human Breast Cancer Cell Line (MCF-7) by Cisplatin and Caffeine
Background: Molecular targeted therapy by different cell death inducers are recently considered in cancer therapy. The aim of this study was to compare the effect of cisplatin and inositol trisphosphate kinase inhibitor (caffeine) on human breast cancer cell line (MCF-7). The pattern of cell death in MCF-7 cells following the exposure to cisplatin and caffeine in individual and combination form...
متن کاملDevelopment and evaluation of macrophage targeted multidrug therapy against visceral leishmaniasis
In this study, we fabricated PCL-nanoparticles by encapsulating dual drugs as amphotericin B and doxorubicin via double-emulsion solvent evaporation method also incorporated with ligand-lectin for targeting the infested macrophage cells and prove importance against VL. Different independent processing parameters were assessed systematically to enhance the incorporation of the dual agents with d...
متن کاملMonoclonal Antibodies as Therapeutic Agents: Advances and Challenges
Despite the major advances in conventional forms of treatment (i.e. surgical techniques, radiotherapy and chemotherapy) and improved survival rates, cancer is still the second leading cause of death in developing countries. One major limitation of cytotoxic drugs and radiation in the treatment of cancer patients is their inability to discriminate between malignant and normal tissues. This in tu...
متن کاملAssessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia
For the past half century, thiopurines have earned themselves a reputation as effective anti-cancer and immunosuppressive drugs. Thiopurine S-methyltransferase (TPMT) is involved in the metabolism of all thiopurines and is one of the main enzymes that inactivates mercaptopurine. 6-MP is now used as a combination therapies for maintenance therapy of children with acute lymphocytic leukemia (A...
متن کامل